The visit is next Tuesday. The scientific benefit may be years away. That timing difference changes how participation is valued.

The direct answer

Immediate burden often outweighs distant clinical trial benefit because people naturally give more weight to costs and rewards they experience now. Travel, time, symptoms, lost work, technology, and caregiver effort are concrete. Future personal or societal benefits may be delayed and uncertain.

Timing changes value.

Temporal discounting describes the tendency for delayed outcomes to carry less weight than immediate ones. In a trial, the burden begins quickly: scheduling, travel, tests, side effects, forms, and uncertainty. The potential benefits may be delayed, indirect, or never personal.

This does not mean patients are short-sighted. It means the trial asks them to exchange certain present effort for uncertain future value.

The full cost is larger than money.

  • Time away from work, school, or family.
  • Transportation, parking, lodging, and meals.
  • Caregiver coordination and dependent care.
  • Physical and emotional recovery after visits.
  • Technology access and administrative effort.
  • Loss of routine, privacy, or control.

A reimbursement policy can cover some expenses while leaving the participation burden largely unchanged.

Reimbursement should remove barriers, not purchase consent.

Compensation and reimbursement require careful ethical review. The practical objective is to prevent patients from carrying costs created by the study. The consent decision must remain voluntary and should not depend on an offer that obscures risk or creates undue influence.

Teams should explain what is reimbursed, when payment occurs, what documentation is required, and whether delays could create hardship.

Make both burden and support concrete.

Patients need a realistic participation map: visit cadence, duration, procedures, likely waiting time, remote requirements, caregiver needs, and what support exists at each point. Future value should also be described honestly, without implying personal benefit.

Readiness improves when the patient can picture the next month, not only the trial's scientific purpose. The more concrete the operating reality, the stronger the decision.

Sources.

  1. Story et al., Temporal discounting and health behavior
  2. Houghton et al., Research burden of randomized trial participation
  3. HHS OHRP, The Belmont Report
  4. FDA, Informed Consent Guidance
Andy Proctor, Head of Behavioral Science at Jumo Health

About the author

Andy Proctor

Head of Behavioral Science

Andy is a social and health psychologist and mixed-methods researcher whose work examines social connection, health behavior, psychophysiology, and human interaction with AI. At Jumo, he translates cognitive, emotional, social, and practical friction into experiences and interventions designed to support durable participation.

Next in The Science of Patient Choice

Trust Moves Through People, Not Materials. →